In silico studies for the rational discovery of anticonvulsant compounds

被引:144
作者
Estrada, E [1 ]
Peña, A
机构
[1] Univ Santiago de Compostela, Dept Organ Chem, Fac Pharm, Santiago De Compostela 15706, Spain
[2] Univ Rostock, Fachbereich Chem, D-18051 Rostock, Germany
关键词
D O I
10.1016/S0968-0896(00)00204-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Theoretical models to virtual screening and rational design of anticonvulsant compounds based on a topological substructural molecular design (TOSS-MODE) approach are developed. These models, developed on the basis of data sets of great structural variability, permit the classification of compounds as active/inactive anticonvulsants and predict the quantitative anticonvulsant potency of such compounds. The classification model is applied to a virtual screening of anticonvulsant compounds by analyzing a data set of molecules reported in the literature. More than 88% of them were well classified by the current model. Active and inactive fragments are identified by using the present approach. Some of the active fragments are identified in anticonvulsant molecules as potential pharmacophores and one of them is analyzed in detail. The three-dimensional (3-D) features of this fragment are investigated in a series of five anticonvulsant compounds. Some structure-anticonvulsant activity relationships are derived on the basis of the 3-D structure of this fragment and some findings reported in the literature that indicate that it is an important pharamacophore are outlined. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2755 / 2770
页数:16
相关论文
共 75 条
[1]  
[Anonymous], 2007, ORGANIC CHEM DRUGS T
[2]  
Basak S.C., 2002, CHEM TOPOLOGY 3 DIME, P73
[3]   Progress report on new antiepileptic drugs: A summary of the Third Eilat Conference [J].
Bialer, M ;
Johannessen, SI ;
Kupferberg, HJ ;
Levy, RH ;
Loiseau, P ;
Perucca, E .
EPILEPSY RESEARCH, 1996, 25 (03) :299-319
[4]   Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV) [J].
Bialer, M ;
Johannessen, SI ;
Kupferberg, HJ ;
Levy, RH ;
Loiseau, P ;
Perucca, E .
EPILEPSY RESEARCH, 1999, 34 (01) :1-41
[5]   DOUBLE-BLIND COMPARISON OF LAMOTRIGINE AND CARBAMAZEPINE IN NEWLY-DIAGNOSED EPILEPSY [J].
BRODIE, MJ ;
RICHENS, A ;
YUEN, AWC .
LANCET, 1995, 345 (8948) :476-479
[6]   LAMOTRIGINE [J].
BRODIE, MJ .
LANCET, 1992, 339 (8806) :1397-1400
[7]  
CAMERMAN A, 1982, ANTIEPILEPTIC DRUGS, P87
[8]   Aroyl(aminoacyl)pyrroles, a new class of anticonvulsant agents [J].
Carson, JR ;
Carmosin, RJ ;
Pitis, PM ;
Vaught, JL ;
Almond, HR ;
Stables, JP ;
Wolf, HH ;
Swinyard, EA ;
White, HS .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (11) :1578-1584
[9]   Identification of a series of 1,2,3,4-tetrahydroisoquinolinyl-benzamides with potential anticonvulsant activity [J].
Chan, WN ;
Hadley, MS ;
Harling, JD ;
Herdon, HJ ;
Jerman, JC ;
Orlek, BS ;
Stean, TO ;
Thompson, M ;
Upton, N ;
Ward, RW .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (20) :2903-2906
[10]   Intra- and inter-subject variabilities of CGP 33101 after replicate single oral doses of two 200-mg tablets and 400-mg suspension [J].
Cheung, WK ;
Kianifard, F ;
Wong, A ;
Mathieu, J ;
Cook, T ;
John, V ;
Redalieu, E ;
Chan, K .
PHARMACEUTICAL RESEARCH, 1995, 12 (12) :1878-1882